Abstract
INTRODUCTION
The European Society of Thoracic Surgeons (ESTS) Database Committee has recently developed new models for risk-adjusting morbidity and mortality from a population of nearly 50 000 patients undergoing anatomical lung resection and registered in the ESTS database from 2007 to 2016 [1] . The new models are intended as instruments to audit quality of care and for risk stratification. The Eurolung1 and Eurolung2 models have been incorporated as elements of the composite performance score used to verify the eligibility for the ESTS Institutional Accreditation [2] [3] [4] , replacing the outdated outcome models.
The good discrimination ability and generalizability of these models make them ideal tools for risk-adjusting performance audits. Therefore, the objective of this study was to apply the ESTS Eurolung risk models for morbidity and mortality as instruments of internal audit of performance in 3 thoracic surgery centres. The rationale was to provide an example of applicability of these risk models for institutional quality monitoring initiatives.
PATIENTS AND METHODS
This is a retrospective analysis performed on data from 3 academic thoracic surgery centres (from the UK, Belgium and Canada) and collected in their respective databases between January 2014 and December 2016. Seven hundred and twentyone patients underwent surgery in Centre 1, 857 in Centre 2 and 433 in Centre 3. The local institution review boards reviewed the †Presented at the 25th European Conference on General Thoracic Surgery, Innsbruck, Austria, 28-31 May 2017. study, and patients provided their consent to use their clinical data for research/audit purposes. This study was classed as service evaluation, and need for the ethical committee approval was waived. All 3 centres are specialized general thoracic surgery units, participating in the ESTS database. The breakdown of operations and surgical access in each centre is listed in Table 1 . Patients undergoing non-anatomical lung resections (wedge) were excluded from the analysis. All 3 units submit their data to the ESTS database on a yearly basis through a central harvesting of their institutional clinical ESTS-compatible databases. Institutional databases of each of the units are used for internal audit and quality improvement initiatives. Quality of data is periodically audited and maintained by institutional data managers, who ensure a high quality of data accuracy between the data registered in the database and the data source. Missing data or discrepancies are periodically checked and corrected if any. All lung resection procedures performed at each centre are systematically and prospectively registered in each institutional database. Thirty-day or in-hospital mortality data are complete and accurate. For the purpose of this analysis, data from the individual institutional databases were merged into a common dataset.
All centres used the same standardized terminology and definition of variables and outcomes [5] .
In all centres, surgical treatment was discussed and agreed during multidisciplinary lung tumour meetings. In general, inoperability criteria were consistent among the 3 centres and included a predicted postoperative forced expiratory volume in 1 s and a predicted postoperative carbon monoxide lung diffusing capacity <30%, in association with a maximum oxygen consumption <10 ml/kg/min, whenever performed [6] .
All patients were operated by board-certified general thoracic surgeons and their perioperative managements followed standardized institutional protocols and pathways of care aimed at surgical pain control, early mobilization, venous thromboembolism prophylaxis, chest physiotherapy and physical rehabilitation.
Statistical analysis
For the purpose of this study and in agreement with variable definition of the ESTS database, cardiopulmonary complications were defined as those occurring in hospital or within 30 days from surgery and included respiratory failure (mechanical ventilation for at least 24 h or need for reintubation at any time), acute respiratory distress syndrome, atrial arrhythmia, ventricular arrhythmia, bronchoscopy for atelectasis, pneumonia, pulmonary embolism, myocardial infarct, acute renal failure and stroke. Each of these complications was defined in accordance with the Society of Thoracic Surgeons (STS) and the ESTS joint standardization of variables [5] .
Similarly, mortality was defined as any death occurring within 30 days or over a longer period if the patient was still in the hospital.
The Eurolung1 and Eurolung2 models were used to predict risk-adjusted cardiopulmonary morbidity and 30-day mortality rates in each centre [1] . These models have been recently developed by the ESTS Database Committee and have shown to be very accurate in the original population [1] .
The following logit was used to estimate the predicted morbidity (EuroLung1): logit (morbidity) = -2.465 + 0.497 Â sex male (coded 1 for male and 0 for female) + 0.026 Â age + 0.231 Â coronary artery disease (coded 1 for presence of coronary artery disease) + 0.371 Â cerebrovascular disease (coded 1 for presence of cerebrovascular disease) + 0.152 Â chronic kidney disease (coded 1 for presence of chronic kidney disease) -0.015 Â predicted postoperative forced expiratory volume in 1 s + 0.514 Â extended resections (coded 1 for presence of extended resection) + 0.497 Â thoracotomy (coded 1 for thoracotomy and 0 for video-assisted thoracoscopic surgery).
Predicted morbidity was extracted by applying the inverse logit function.
The following logit was used to estimate 30-day mortality (EuroLung2): logit (mortality) = -5.82 + 0.903 Â sex male (coded 1 for male and 0 for female) + 0.044 Â age + 0.264 Â CAD (coded 1 for presence of coronary artery disease) + 0.582 Â CVD (coded 1 for presence of cerebrovascular disease) -0.064 Â body mass index-+ 0.300 Â extended resection (coded 1 for extended resection) + 0.929 Â pneumonectomy (coded 1 for pneumonectomy and 0 for lesser resection) + 0.894 Â thoracotomy (coded 1 for thoracotomy and 0 for video-assisted thoracoscopic surgery) -0.009 Â predicted postoperative forced expiratory volume in 1 s.
Predicted mortality was extracted by applying the inverse logit function. All variables used to calculate the Eurolung models were complete.
Risk-adjusted outcomes were calculated in each centre according to the following formula: [(average observed outcome/ average predicted outcome) Â observed outcome reported in the total population of the ESTS database]. The observed cardiopulmonary morbidity and 30-day mortality rates in the total population of approximately 50 000 patients undergoing anatomical lung resections as reported in the original Eurolung paper were 18.4% and 2.7%, respectively [1] . These rates were used to calculate the risk-adjusted morbidity and mortality rates using the aforementioned formula.
Failure to rescue rates was also estimated by assessing the mortality rate occurring within the group of patients with major complications. Major complications were defined as those with a Thoracic Morbidity and Mortality (TMM) grade between 3 and 5 [7, 8] .
The baseline and surgical characteristics of the patients who underwent surgery in the 3 different centres are listed in Table 1 and compared using the analysis of variance (ANOVA) test. Differences between the 3 centres were tested for exploratory purpose.
The comparison of individual complications observed in each centre is reported in Table 2 and differences between centres are reported as trend analysis using the ANOVA test to show unbalances, which may have interesting clinical implications during the individual analysis of the pathways of care at each centre.
A binomial proportion test was used to compare the predicted and observed outcomes within each centre.
All tests were performed using the Stata 12.0 statistical software (StataCorp, College Station, TX, USA).
RESULTS
The characteristics of the patients included in this study are listed in Table 1 .
Overall cardiopulmonary complications and 30-day mortality rates were 25.0% and 2.1%, respectively. The Eurolung-predicted morbidity and mortality rates were 24.7% and 2.3%, respectively.
Analysis of morbidity
The observed morbidity of Centre 1 was in line with the predicted one (observed 21.1% vs predicted 22.7%, P = 0.31). Centre 2 performed better than expected (observed morbidity 20.2% vs predicted 26.7%, P < 0.001), whereas the observed morbidity of Centre 3 was higher than the predicted one (observed 41.1% vs predicted 24.3%, P < 0.001).
Risk-adjusted cardiopulmonary morbidity rates were 17.1% in Centre 1, 13.9% in Centre 2 and 31.1% in Centre 3.
Analysis of mortality
Centre 1 had higher observed mortality when compared with the predicted one (3.6% vs 2.1%, P = 0.005), whereas Centre 2 had an observed mortality rate significantly lower than the predicted one (1.2% vs 2.5%, P = 0.013). Centre 3 had an observed mortality rate in line with the predicted one (observed 1.4% vs predicted 2.4%, P = 0.17).
Risk-adjusted mortality rates were 3.6% in Centre 1, 1.3% in Centre 2 and 1.4% in Centre 3.
The observed mortality rates in patients with major complications (defined according to the TMM grading system between 3 and 5) were 30.8% in Centre 1 (versus predicted mortality 3.8%, P < 0.001), 8.2% in Centre 2 (versus predicted mortality 4.1%, P = 0.030) and 9.0% in Centre 3 (versus predicted mortality 3.5%, P = 0.014).
DISCUSSION

Background and objective
Risk modelling is essential when using outcome indicators for performance assessment. In fact outcomes may vary based on patient characteristics and surgical complexity. The ESTS has recently updated their risk-adjusting morbidity and mortality models [1] . These models are in use to calculate risk-adjusted outcomes as part of the composite performance score [3, 4] applied to assess eligibility for the European Institutional Accreditation.
Risk models can also be used to audit internal performance over a certain period of time (internal audit) or as instruments to allow for a fair comparison between different centres (external audit). The objective of this study was to apply for the first time the Eurolung models to assess the internal performance of 3 different centres with the intent to prove its external applicability for future quality audit purposes.
Interpretation of the main findings
The first finding of this analysis was the discrepancy between the morbidity and mortality results. We found that 1 centre clearly underperformed when compared with the others in terms of incidence cardiopulmonary complications, whereas a different one had mortality rates higher than predicted. This discrepancy is not a new finding in the surgical literature, and it is explained, in part, by the fact that morbidity and mortality reflect different aspect of quality [9] . Morbidity is more linked to patient characteristics, whereas mortality might also be associated with system characteristics. This highlights the problem of using outcome indicators in isolation when assessing the performance of surgical units. As shown in our analysis, this approach appears unreliable and can provide misleading or incomplete information.
As listed in Table 2 , the higher morbidity rate of Centre 3 can be explained by the higher incidence of pneumonia. This finding will trigger a local audit to investigate the cause of it. One of the possible reasons may be a problem of classification due to a less strict definition of this type of complication leading to its overrecording in the database. Indeed, when complications are used as quality end-points, there may be inherent problems of reporting, miscoding and definition [10, 11] . These problems may have played a role in this analysis, despite all units declared to use standard definitions of variables and outcomes [5] .
We were able to detect a clear underperformance in unit 1 when mortality was used as end-point. In this unit, both the observed and the risk-adjusted mortality rates were higher than the predicted mortality rate.
The use of the risk models confirmed that the increased observed mortality rate was not due to a different and more compromised case mix or higher surgical complexity. Other reasons will need to be sought to explain this finding, which was even more striking in light of the observed morbidity rate that was in line with the expected one in this particular unit as discussed earlier. It is evident that there was a failure to rescue problem. In fact, the risk-adjusted mortality among the patients with major complications (failure to rescue rate) in Centre 1 was 4-fold higher when compared with the other 2 centres and almost 10-fold higher than the predicted one.
Failure to rescue rate is an important quality metric focusing primarily on the system of care rather than the surgical procedure. It has been recognized as an important quality measure complementing the more traditional outcomes such as morbidity and mortality [12] [13] [14] [15] . Hospital characteristics associated with high quality of care are more associated with lower rates of mortality or failure to rescue rather than with complications [9] . The lack of correlation between the different outcome indicators is well represented by our findings. The centre with the worse riskadjusted mortality had an observed complication rate in line with the expected one. This translated into the highest failure to rescue rate, which hinted at some system failure in the perioperative pathway of care.
A careful root cause analysis auditing all process of care involved in the perioperative pathway of lung cancer surgical patients will be needed to detect possible critical areas in Centre 1 warranting changes. In particular, the root cause analysis should be directed towards the care of the patients at the highest risk of major complications as they are the ones most exposed to unexpectedly high mortality rate.
In this regard, an audit analysis such as the present one will be useful as successful pathways of care applied in those centres with better performance (lower risk-adjusted mortality and failure to rescue rates and predicted outcomes in line with the expected ones) can be reviewed and possibly applied to the underperforming centres. Mechanisms should be designed and implemented to facilitate positive cross-contamination of highquality standards of care.
Scientific organizations would be best suited to put in place such mechanisms aimed not only at detecting underperformance but also at improving critical areas of care by sharing successful models (i.e. those used in units with better performance) [16] .
A similar analysis was published several years ago using the European Society Objective Score (ESOS) risk model and comparing the risk-adjusted mortality of 3 units [17] . At variance with that study, we now applied the revised Eurolung risk models for both morbidity and 30-day mortality and were able to assess the internal performance of the 3 centres by using both end-points. We believe that this approach is more comprehensive when compared with the former one inasmuch as it used more than one outcome indicator.
Ideally, institutions or surgeons should be assessed by applying as many outcome indicators as possible or through the combination of process and outcome quality metrics. The incorporation of the Eurolung models in the ESTS composite performance score is an example of such application for quality initiatives and credentialing purposes [3, 4] .
Limitations
This study has potential limitations.
• This analysis has inherent bias on the retrospective analysis with multi-institutional database. Although the ESTS/STS standardization of variables initiative has reduced the variability in defining complications, we cannot rule out that different health systems may have their guidelines for monitoring and treating these complications.
• As discussed earlier, the use of morbidity in the context of comparative audit may have inherent bias of recording and misclassification. The complications in this study were not weighted. The use of a grading system in this context (i.e. the TMM grading system [7] ) may facilitate external audit of performance introducing a criteria of standardization and adjustment (i.e. taking into account only major complications).
• The audit is limited to anatomical lung resections only. It does not take into the account other procedures or non-operated patients (i.e. those excluded from surgery or undergoing nonsurgical treatment), which may be another interesting aspect of quality to analyse. However, this was outside the scope of this work primarily set to test the applicability of the Eurolung models in the clinical scenario.
• Some of the patients included in this study from the 3 centres were used in the pool of patients used to develop the risk models from the ESTS database. In particular, 400 patients from Centre 1 and 240 from Centre 3 were part of the sample used to develop the Eurolung models. On the other hand, none of the patients who underwent surgery in Centre 2 were used to develop the models. Overall, the patients of Centres 1 and 3 included in the original population used to develop the Eurolung models represent only 4% of the total population used for that purpose [1] . We did not aim to validate the models. The aim was to apply the models to verify the performances of the individual units, and we believe that their use in this context seems appropriate. Nevertheless, we cannot rule out that the adjusting models may perform differently in the group of patients undergoing surgery in the unit, which was completely independent of the Eurolung derivation setting (Centre 2) when compared with the other 2 centres.
• Patients from units outside Europe were not included in the population used to develop the original models from the ESTS database [1] . We cannot rule out that some of the findings observed in this study may be explained in part by geographical differences not taken into the account in the model. • Finally, although mortality is certainly a less ambiguous indicator than morbidity, it has the inherent limitation of being a rare event. Even the most reliable risk model generated from a large multicentre database (i.e. Eurolung) can have this problem when applied to individual units [18] . This may have been the case in this study in which we observed only 42 deaths in total, with some of the centres observing 10 or less events. This should be taken into account when interpreting differences in the comparative analysis.
Clinical implications
Eurolung risk models can be reliably used to assist the internal audit of performance.
Sharing the results of risk-adjusted internal performance audits at different centres can lead to a positive cross-contamination by identification of ineffective elements in the perioperative pathways of care and implementation of successful elements used in the centres with better performance.
